Chongqing Land Tower Pharmaceutical Co., Ltd. – FDA Inspection, Apr 14, 2017

Record Details

This FDA Inspection record concerns Chongqing Land Tower Pharmaceutical Co., Ltd., with an inspection on April 14, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Chongqing Land Tower Pharmaceutical Co., Ltd.
Inspection Date: April 14, 2017
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Liming Zhang (FDA Associated Person)

View Company Profile

ID · e1c0ba24-af85-4245-81a9-03a6fc72fc0a

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1017659
FDA center: Human Drugs
Project area: Drug Quality Assurance
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Chongqing Land Tower Pharmaceutical Co., Ltd.

FDA Inspection

Chongqing Land Tower Pharmaceutical Co., Ltd.April 14, 2017